These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25807647)

  • 41. Mutations in reverse transcriptase region of HBV affect Hepatitis B surface antigen titers and its correlation with HBV DNA.
    Shen H; Chen C; Ye C; Zhang H; Hang S; Chen M; Zhu Z; Xue Y; Liu L
    J Infect Dev Ctries; 2019 Nov; 13(11):1062-1067. PubMed ID: 32087080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment.
    Ozaras R; Tabak F; Tahan V; Ozturk R; Akin H; Mert A; Senturk H
    Dig Dis Sci; 2008 Nov; 53(11):2995-8. PubMed ID: 18409002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantification of HBsAg in nucleos(t)ide-naïve patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW study.
    Zoulim F; Carosi G; Greenbloom S; Mazur W; Nguyen T; Jeffers L; Brunetto M; Yu S; Llamoso C
    J Hepatol; 2015 Jan; 62(1):56-63. PubMed ID: 25176615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elecsys hepatitis B surface antigen quantitative assay: performance evaluation and correlation with hepatitis B virus DNA during 96 weeks of follow-up in chronic hepatitis B patients.
    Lee HJ; Kim SY; Lee SM; Heo J; Kim HH; Chang CL; Lee EY; Son HC
    Ann Lab Med; 2012 Nov; 32(6):420-5. PubMed ID: 23130341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment.
    Wu F; Wu MJ; Zhuge XL; Zhu SM; Zhu B
    Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):172-6. PubMed ID: 22484586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants.
    Mühlbacher A; Weber B; Bürgisser P; Eiras A; Cabrera J; Louisirirotchanakul S; Tiller FW; Kim HS; v Helden J; Bossi V; Echevarria JM
    Med Microbiol Immunol; 2008 Mar; 197(1):55-64. PubMed ID: 17899185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay.
    Chung KH; Kim W; Kim BG; Lee HY; Jin E; Cho Y; Seo JY; Kim HY; Jung YJ; Kim JW; Jeong JB; Lee KL
    Gut Liver; 2015 Sep; 9(5):657-64. PubMed ID: 25717049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: on-treatment kinetics of HBsAg serum levels vary by HBV genotype.
    Brunetto MR; Marcellin P; Cherubini B; Yurdaydin C; Farci P; Hadziyannis SJ; Rothe V; Regep L; Bonino F
    J Hepatol; 2013 Dec; 59(6):1153-9. PubMed ID: 23872601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.
    Li J; Sun X; Fang J; Wang C; Han G; Ren W
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):635-643. PubMed ID: 28438570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels.
    Sonneveld MJ; Hansen BE; Piratvisuth T; Jia JD; Zeuzem S; Gane E; Liaw YF; Xie Q; Heathcote EJ; Chan HL; Janssen HL
    Hepatology; 2013 Sep; 58(3):872-80. PubMed ID: 23553752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Affects of HBV genotypes (B/C) on the levels of serum and intrahepatic HBsAg].
    Chen JJ; Ma SW; Wang ZH; Sun J; Zhu YF; Hou JL
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1947-51. PubMed ID: 17064586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An ultra-sensitive Abbott ARCHITECT
    Lou S; Taylor R; Pearce S; Kuhns M; Leary T
    J Clin Virol; 2018 Aug; 105():18-25. PubMed ID: 29843004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [HBV pol/S gene mutations in chronic hepatitis B patients receiving nucleoside/nucleotide analogues treatment].
    Kırdar S; Yaşa MH; Sayan M; Aydın N
    Mikrobiyol Bul; 2019 Apr; 53(2):144-155. PubMed ID: 31130119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays.
    Louisirirotchanakul S; Khupulsup K; Akraekthalin S; Chan KP; Saw S; Aw TC; Cho DH; Shin MG; Lim J
    J Med Virol; 2010 May; 82(5):755-62. PubMed ID: 20336717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.
    Yuan Q; Song LW; Cavallone D; Moriconi F; Cherubini B; Colombatto P; Oliveri F; Coco BA; Ricco G; Bonino F; Shih JW; Xia NS; Brunetto MR
    PLoS One; 2015; 10(6):e0130209. PubMed ID: 26115521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantification of hepatitis B e antigen between Elecsys HBeAg and Architect HBeAg assays among patients infected with hepatitis B virus.
    Maylin S; Boyd A; Martinot-Peignoux M; Delaugerre C; Bagnard G; Lapalus M; Zoulim F; Lavocat F; Marcellin P; Simon F; Girard PM; Lacombe K
    J Clin Virol; 2013 Apr; 56(4):306-11. PubMed ID: 23369885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
    Paik YH; Han KH; Hong SP; Lee HW; Lee KS; Kim SO; Shin JE; Ahn SH; Chon CY; Moon YM
    Antivir Ther; 2006; 11(4):447-55. PubMed ID: 16856618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical implications of hepatitis B surface antigen quantitation in the natural history of chronic hepatitis B virus infection.
    Tan Z; Li M; Kuang X; Tang Y; Fan Y; Deng G; Wang Y; He D
    J Clin Virol; 2014 Apr; 59(4):228-34. PubMed ID: 24529415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.
    Tseng TC; Kao JH
    J Gastroenterol; 2013 Jan; 48(1):13-21. PubMed ID: 23090000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology?
    Galli C; Orlandini E; Penzo L; Badiale R; Caltran G; Valverde S; Gessoni G
    J Med Virol; 2008 Jun; 80(6):974-9. PubMed ID: 18428144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.